Your browser doesn't support javascript.
loading
Investigation of the enhanced antitumour potency of STING agonist after conjugation to polymer nanoparticles.
Dosta, Pere; Cryer, Alexander M; Dion, Michelle Z; Shiraishi, Tsubasa; Langston, Steven P; Lok, David; Wang, Jianing; Harrison, Sean; Hatten, Tiquella; Ganno, Michelle L; Appleman, Vicky A; Taboada, Gonzalo Muñoz; Puigmal, Núria; Ferber, Shiran; Kalash, Santhosh; Prado, Michaela; Rodríguez, Alma L; Kamoun, Walid S; Abu-Yousif, Adnan O; Artzi, Natalie.
  • Dosta P; Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA. pdostapons@bwh.harvard.edu.
  • Cryer AM; Department of Medicine, Division of Engineering in Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. pdostapons@bwh.harvard.edu.
  • Dion MZ; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA. pdostapons@bwh.harvard.edu.
  • Shiraishi T; Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Langston SP; Department of Medicine, Division of Engineering in Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Lok D; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.
  • Wang J; Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Harrison S; Department of Medicine, Division of Engineering in Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Hatten T; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.
  • Ganno ML; Harvard-MIT Division of Health Sciences & Technology, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Appleman VA; Takeda Development Center Americas, Inc. (TDCA), Lexington, MA, USA.
  • Taboada GM; Takeda Development Center Americas, Inc. (TDCA), Lexington, MA, USA.
  • Puigmal N; Takeda Development Center Americas, Inc. (TDCA), Lexington, MA, USA.
  • Ferber S; Takeda Development Center Americas, Inc. (TDCA), Lexington, MA, USA.
  • Kalash S; Takeda Development Center Americas, Inc. (TDCA), Lexington, MA, USA.
  • Prado M; Takeda Development Center Americas, Inc. (TDCA), Lexington, MA, USA.
  • Rodríguez AL; Takeda Development Center Americas, Inc. (TDCA), Lexington, MA, USA.
  • Kamoun WS; Takeda Development Center Americas, Inc. (TDCA), Lexington, MA, USA.
  • Abu-Yousif AO; Biodevek, Cambridge, MA, USA.
  • Artzi N; Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA.
Nat Nanotechnol ; 18(11): 1351-1363, 2023 Nov.
Article en En | MEDLINE | ID: mdl-37443252
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Nanopartículas / Melanoma / Neoplasias Límite: Animals Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Nanopartículas / Melanoma / Neoplasias Límite: Animals Idioma: En Año: 2023 Tipo del documento: Article